United States - English - NLM (National Library of Medicine)

united exchange corp. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.05 mg in 100 ml - uses temporarily relieves nasal congestion due to: - common cold - hay fever - upper respiratory allergies - temprarily relievves sinus congestion and pressure - shrinks swollen nasal membranes so you can breathe more freely stop use and ask a doctor if symptoms persist directions - adults and children 6 to 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. do not exceed 2 doses in any 24-hour period. - children under 8 years of age: ask a doctor. shake well before use. to open, rotate cap to align the marks. squeeze cap on both sides in a counter-clockwise turn and pull off to remove. to spray, remove clamp and hold bottle with thumb at base and nozzle between first and second fingers. without tiliting the head, insert nozzle into nostril. fully depress rim with a firm, even stroke and sniff deeply. wipe nozzle clean after use and snap cap back onto the bottle.

United States - English - NLM (National Library of Medicine)

greenbrier international, inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.05 mg in 100 ml - uses - temporarily relieves nasal congestion due to: - common cold - hay fever - upper respiratory allergies - sinusitis - shrinks swollen nasal membranes so you can breathe more freely stop use and ask a doctor if symptoms persist directions - adults and children 6 to 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. do not exceed 2 doses in any 24-hour period. - children under 8 years of age: ask a doctor. to spray, hold bottle with thumb at base and nozzle between first and second fingers. without tilting head, insert nozzle into nostril. fully depress rim with a firm, even stroke and sniff deeply. wipe nozzle clean after use.

United States - English - NLM (National Library of Medicine)

greenbrier international, inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.05 g in 100 ml - uses - temporarily relieved nasal congestion due to: - common cold - hay fever - upper respiratory allergies - sinusitis - shrinks swollen nasal membranes so you can breathe more freely stop use and ask a doctor if symptoms persist directions - adults and children 6 to 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours.  do not exceed 2 doses in any 24-hour period. - children under 6 years of age: ask a doctor. to open, rotate cap to align the marks. squeeze cap on both sides in a counter-clockwise turn and pull off to remove. to srapy, remove clamp and hold bottle with thumb at base and nozzle between first and second fingers. without tiliting the head, insert nozzle into nostril. fully depress rim with a firm, even stroke and sniff deeply. wipe nozzle clean after use and snap cap back onto the bottle.

United States - English - NLM (National Library of Medicine)

we care distributor inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 5 g in 100 ml - nasal decongestant - temporary relieves nasal congestion due to: - common cold - hay fever - upper respiratory allergies - sinusitis - shrinks swollen nasal membranes so you can breathe more freely

United States - English - NLM (National Library of Medicine)

matrixx initiatives, inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride .5 mg in 1 ml - nasal decongestant - temporarily relieves nasal congestion due to: the common cold hay fever upper respiratory allergies - the common cold - hay fever - upper respiratory allergies - temporarily relieves sinus congestion and pressure - helps clear nasal passages - shrinks swollen membranes

United States - English - NLM (National Library of Medicine)

chain drug marketing association inc - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hci 0.05% ....... nasal decongestant - rapid & powerful congestion relief - temporarily relieves nasal congestion due to: common cold hay fever upper respiratory allergies  - common cold - hay fever - upper respiratory allergies  - temporarily relieves sinus congestion and pressure - shrinks swollen nasal membranes so you can breathe more freely stop use and ask a doctor if symptoms persist.

United States - English - NLM (National Library of Medicine)

chain drug marketing association inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hcl 0.05%............. nasal decongestant nasal decongestant - temporarily relieves nasal congestion due to: common cold hay fever upper respiratory allergies - common cold - hay fever - upper respiratory allergies - shrinks swollen nasal membranes so you can breathe more freely stop use and ask a doctor if symptoms persist. if pregnant or breast-feeding , ask a health professional before use.

United States - English - NLM (National Library of Medicine)

chain drug marketing association inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hcl 0.05%............. nasal decongestant nasal decongestant - temporarily relieves nasal congestion due to: common cold hay fever upper respiratory allergies - common cold - hay fever - upper respiratory allergies - shrinks swollen nasal membranes so you can breathe more freely stop use and ask a doctor if symptoms persist. if pregnant or breast-feeding , ask a health professional before use.

United States - English - NLM (National Library of Medicine)

aclaris therapeutics, inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - rhofade® (oxymetazoline hydrochloride) cream, 1% is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. none. risk summary there are no available data on rhofade cream use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. a literature article describing intranasal decongestant use in pregnant women identified a potential association between second-trimester exposure to oxymetazoline (with no decongestant exposure in the first trimester) and renal collecting system anomalies [see data] . in animal reproduction studies, there were no adverse developmental effects observed after oral administration of oxymetazoline hydrochloride in pregnant rats and rabbits at systemic exposures up to 3 times and 73 times, respectively, the exposure associated with the maximum recommended human dose (mrhd) [see data] . the estimated background risks of major birth defects and miscarriage for the indicated population are unknown. all p

United States - English - NLM (National Library of Medicine)

epi health, llc - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - rhofade® (oxymetazoline hydrochloride) cream, 1% is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. none. risk summary there are no available data on rhofade cream use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. a literature article describing intranasal decongestant use in pregnant women identified a potential association between second-trimester exposure to oxymetazoline (with no decongestant exposure in the first trimester) and renal collecting system anomalies [see data] . in animal reproduction studies, there were no adverse developmental effects observed after oral administration of oxymetazoline hydrochloride in pregnant rats and rabbits at systemic exposures up to 3 times and 73 times, respectively, the exposure associated with the maximum recommended human dose (mrhd) [see data] . the estimated background risks of major birth defects and miscarriage for the indicated population are unknown. all pregn